Please login to the form below
cancer
This page shows the latest cancer news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
More than 52, 000 men are diagnosed with prostate cancer every year in the UK alone. ... a range of indications for ovarian, breast, fallopian tube, peritoneal and pancreatic cancers.
Latest news
-
WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
Also known as chronic diseases, the main types of NCDs are cardiovascular diseases, cancers, chronic respiratory diseases and diabetes.
-
MHRA to introduce new UK clinical trials framework
to meet the UK’s healthcare priorities’, such as cancer vaccines.
-
Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
The treatment is already approved in the US for three disease states of prostate cancer. ... Pfizer and Astellas have reported positive top line results from a phase 3 trial of their androgen receptor signalling inhibitor, Xtandi (enzalutamide), in
-
US government announces first set of drugs subject to Medicare inflation rebates
The 27 products, which all fall under Medicare Part B, include Gilead Sciences’ blood cancer therapies Yescarta and Tecartus, AbbVie’s immunology drug Humira, Seagen’s Padcev for bladder cancer and ... Roche’s lung cancer therapy Rybrevant.
-
Roche’s Polivy backed by FDA Advisory Committee for lymphoma therapy
aggressive form of blood cancer.
More from news
Approximately 919 fully matching, plus 3,359 partially matching documents found.
Latest Intelligence
-
Rare diseases: not so rare after all
Some, like haemophilia, cystic fibrosis, or childhood cancers (such as osteosarcoma), attract considerable public attention, but most don’t. ... When the technology was new, these antibodies were used predominantly in the treatment of cancer.
-
A new age of innovation in healthcare
Although lifespan in Europe is increasing, so too are the healthcare challenges society is facing, with more than four million people diagnosed with cancer annually, and this is forecast to reach ... People are afraid of the pain or embarrassment of some
-
Biosimilars and beyond: innovating for improved patient outcomes
profile. Biosimilars are used to treat a vast range of conditions, including chronic diseases such as rheumatoid arthritis, as well as certain types of cancers.
-
World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
The result? 70% of all cancer deaths in 2020 were in low- and middle-income countries. ... communities have higher odds of later-stage diagnoses of breast and lung cancers.
-
The challenges of identifying rare diseases
After excluding rare cancers, infectious diseases and poisonings, this study estimated that 262.9 to 446.2 million people worldwide are affected by a rare disease.
More from intelligence
Approximately 8 fully matching, plus 371 partially matching documents found.
Latest appointments
-
Hanover Health appoints James Mole as a director
With fifteen years’ experience of working with government, parliament and healthcare charities – including Cancer Research UK, Diabetes UK and the Alzheimer's Society – Butterworth has a proven track record in senior
-
Mark Caulfield departs from Genomics England to take on CEO role at Barts Life Sciences
First launched in 2012, the 100, 000 Genome Project had ambitious plans to map the genomes of NHS patients to deliver treatments for those with rare inherited diseases and cancer.
-
AZ appoints Susan Galbraith as executive vice president, oncology R&D
I am honoured to take on this position as we continue our work to one day cure cancer.
-
Virtual agency The Difference Collective makes new hires to senior team
Levy, a published author of research into the needs of men with advanced prostate cancer, also brings over ten years of experience in the healthcare sector to the team.
-
ICR appoints Kristian Helin as its new chief executive
Helin will join ICR in September from the Memorial Sloan Kettering Cancer Center in the US. ... The Institute of Cancer Research, London has appointed Kristian Helin (pictured above) as its new chief executive, with the ‘world-leading’ cancer
More from appointments
Approximately 5 fully matching, plus 214 partially matching documents found.
Latest from PMHub
-
Mednet Group’s growth spurt
Her interests are in cancer biology and she has experience working as a research technician in the field of malignant haematology.
-
Could femtech be the answer to the gender health gap?
Published March 11, 2015. Accessed November 3, 2021. Knowles K. This start-up is 3D printing breast implants for cancer survivors. ... Accessed November 3, 2021. World Health Organisation. A cervical cancer-free future: First-ever global commitment to
-
Breaking the silence: It’s time to talk about the menopause
of breast cancer among those included in the study. ... Although the risk of cancer was in actual fact much higher among older study participants (and later analysis of the data has shown fewer cancers in the age group 50-59
-
End-to-end patient strategy: Making a treatment for patients, with patients
Nature Medicine.2022; 28:1520-1522. Spreafico, A et al. Cancer Discovery. 2021; 11(4):822-837. .
-
Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
Kate Shaw, Innovative Trials' Founder &CEM, reflects on the exciting news for patients affected by cancer in the UK. ... Kate Shaw, Founder &CEO of Innovative trials, welcomes the news that 29 UK experimental cancer medicine centers (ECMCs) are set to
More from PMHub
Approximately 51 fully matching, plus 250 partially matching documents found.
Subscribe to our email news alerts
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- VR/AR Applications for Training and Healthcare
PMHub
Branding Science
We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
